Correlation Between NextCure and Zura Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NextCure and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NextCure and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NextCure and Zura Bio Limited, you can compare the effects of market volatilities on NextCure and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NextCure with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of NextCure and Zura Bio.

Diversification Opportunities for NextCure and Zura Bio

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between NextCure and Zura is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding NextCure and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and NextCure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NextCure are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of NextCure i.e., NextCure and Zura Bio go up and down completely randomly.

Pair Corralation between NextCure and Zura Bio

Given the investment horizon of 90 days NextCure is expected to generate 6.31 times less return on investment than Zura Bio. But when comparing it to its historical volatility, NextCure is 3.87 times less risky than Zura Bio. It trades about 0.01 of its potential returns per unit of risk. Zura Bio Limited is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  816.00  in Zura Bio Limited on September 3, 2024 and sell it today you would lose (511.00) from holding Zura Bio Limited or give up 62.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy86.87%
ValuesDaily Returns

NextCure  vs.  Zura Bio Limited

 Performance 
       Timeline  
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Zura Bio Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NextCure and Zura Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NextCure and Zura Bio

The main advantage of trading using opposite NextCure and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NextCure position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.
The idea behind NextCure and Zura Bio Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio